Literature DB >> 3748352

Leptomeningeal metastasis from supratentorial malignant gliomas.

I Awad, J W Bay, L Rogers.   

Abstract

The clinical and diagnostic findings in 13 patients with leptomeningeal metastasis from supratentorial malignant gliomas are reported. Criteria for inclusion in this study were positive myelographic examination, positive cerebrospinal fluid cytology on two or more samples, or evidence of leptomeningeal seeding at autopsy. Eight patients had premortem symptoms of leptomeningeal metastasis, with the diagnosis confirmed during life in 5 patients. Average survival after the onset of symptoms was 3 months (range, 1 to 5 months). Comparison of the autopsied group with 10 concurrent autopsied patients without leptomeningeal gliomatosis did not reveal any significant differences in age, but leptomeningeal gliomatosis was more prevalent in patients with longer postoperative survival. Leptomeningeal involvement at autopsy was more extensive in symptomatic patients. Cerebrospinal fluid examination often gave nondiagnostic or nonspecific results. Computed tomography of the brain showed evidence of ventriculomegaly, periventricular contrast enhancement, or multifocal tumor involvement in every case. Iophendylate myelography was the most reliable diagnostic tool and established the diagnosis whenever performed. The natural history and clinical significance of leptomeningeal metastasis from supratentorial malignant gliomas are discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3748352     DOI: 10.1227/00006123-198608000-00010

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  30 in total

Review 1.  Extraneural metastases of primary brain tumors.

Authors:  T Schweitzer; G H Vince; C Herbold; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

2.  Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology.

Authors:  Tae-Young Jung; Ji Yeoun Lee; Dong-Seok Kim; Hyeon Jin Park; Chae-Yong Kim; Young-Shin Ra; Mee-Jeong Lee; Seong-Ho Kim; Hee-Jo Baek; Il Han Kim; Kyung Duk Park; Seung-Ki Kim
Journal:  J Neurooncol       Date:  2014-11-04       Impact factor: 4.130

3.  Isolated oculomotor nerve palsy: an unusual presentation of glioblastoma multiforme. Case report and review of the literature.

Authors:  M al-Yamany; A al-Shayji; M Bernstein
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

4.  Freiburg neuropathology case conference: widespread mass lesions after resection of a glioblastoma multiforme.

Authors:  C A Taschner; S Brendecke; A Weyerbrock; K Egger; M Prinz
Journal:  Clin Neuroradiol       Date:  2012-11-07       Impact factor: 3.649

5.  Symptomatic spinal dissemination of malignant astrocytoma.

Authors:  Ryuta Saito; Toshihiro Kumabe; Hidefumi Jokura; Reizo Shirane; Takashi Yoshimoto
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

6.  Treatment of meningeal gliomatosis.

Authors:  P F Pradat; K Hoang-Xuan; P Cornu; K Mokhtari; N Martin-Duverneuil; M Poisson; J Y Delattre
Journal:  J Neurooncol       Date:  1999-09       Impact factor: 4.130

7.  Spinal metastases of cerebral glioma. Case report.

Authors:  D Koch
Journal:  Neurosurg Rev       Date:  1996       Impact factor: 3.042

8.  Comparative Analysis of Subventricular Zone Glioblastoma Contact and Ventricular Entry During Resection in Predicting Dissemination, Hydrocephalus, and Survival.

Authors:  Akshitkumar M Mistry; Patrick D Kelly; Jean-Nicolas Gallant; Nishit Mummareddy; Bret C Mobley; Reid C Thompson; Lola B Chambless
Journal:  Neurosurgery       Date:  2019-11-01       Impact factor: 4.654

Review 9.  Spinal canal metastases: a late complication of glioblastoma.

Authors:  M Schwaninger; S Patt; P Henningsen; D Schmidt
Journal:  J Neurooncol       Date:  1992-01       Impact factor: 4.130

Review 10.  Primary diffuse leptomeningeal gliomatosis (PDLG): a neoplastic cause of chronic meningitis.

Authors:  P Y Dietrich; M S Aapro; A Rieder; G P Pizzolato
Journal:  J Neurooncol       Date:  1993-03       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.